2025-05-24

Table of Contents

  1. Introduction
  2. Common Blood Markers for Diagnosing Sepsis
  3. Joinstar Company Solutions
  4. Conclusion
  5. References

Introduction

Sepsis is a life-threatening condition that arises when the body's response to an infection injures its own tissues and organs. Early diagnosis is essential for improving patient outcomes, making the identification of reliable blood markers crucial.

Common Blood Markers for Diagnosing Sepsis

Diagnosis of sepsis typically involves several blood markers which aid in assessing the presence and severity of the condition. The following markers are commonly evaluated:

  • C-reactive Protein (CRP): Elevated levels, typically greater than 100 mg/L, may indicate an acute inflammatory response.
  • Procalcitonin (PCT): Levels greater than 0.5 ng/mL can suggest bacterial infection, which is often associated with sepsis.
  • White Blood Cell Count (WBC): An abnormal count, either high (>12,000 cells/μL) or low (<4,000 cells/μL), can be an indicator of sepsis.
  • Lactate: Elevated lactate levels, greater than 2 mmol/L, can imply tissue hypoperfusion caused by sepsis.

Joinstar Company Solutions

Joinstar Biomedical Technology Co., Ltd. offers innovative diagnostic solutions tailored for the detection and management of sepsis:

  • Joinstar Fast Reader: A rapid testing device allowing for the point-of-care measurement of key sepsis markers such as CRP and PCT. This device delivers results within 15 minutes, assisting in timely clinical decisions.
  • Bioassay Kits: Joinstar provides high-quality bioassay kits for the quantitative analysis of sepsis-related markers. These kits are designed to ensure precision and accuracy in laboratory settings.

Conclusion

The detection of sepsis relies heavily on the evaluation of specific blood markers. Technologies developed by companies like Joinstar contribute significantly by providing rapid and accurate testing solutions. These advances are key in improving sepsis management and patient outcomes.

References

  1. Levy MM, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Medicine. 2003.
  2. Bone RC, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992.
  3. Sepsis Fact Sheet. World Health Organization, 2023.
  4. Joinstar Biomedical Technology Co., Ltd. Official Website. https://www.joinstar.com.

User keyword search:Sepsis Blood Markers

Joinstar brand gives you a solution